Detalhe da pesquisa
1.
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.
Eur J Epidemiol;
38(10): 1053-1068, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37789226
2.
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.
Sci Rep;
12(1): 6199, 2022 04 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35418701
3.
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.
Cancer Res Commun;
2(4): 211-219, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36303815
4.
Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.
Br J Clin Pharmacol;
69(5): 516-9, 2010 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20573087
5.
Hydrolysis of dinitrobenzamide phosphate prodrugs: the role of alkaline phosphatase.
Drug Metabol Drug Interact;
24(1): 1-16, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19353998
6.
Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer.
Epigenomics;
11(1): 81-93, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30208740
7.
Cancer-Associated Intermediate Conductance Ca2+-Activated K⺠Channel KCa3.1.
Cancers (Basel);
11(1)2019 Jan 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30658505
8.
A rare diagnostically challenging case of CIC-DUX4 sarcoma arising in the neck.
Pathology;
55(4): 568-571, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35691724
9.
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods.
Geburtshilfe Frauenheilkd;
77(6): 667-678, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28757654
10.
SK4 channels modulate Ca2+ signalling and cell cycle progression in murine breast cancer.
Mol Oncol;
11(9): 1172-1188, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28557306
11.
Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.
Eur J Cancer;
49(17): 3598-608, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23968733